{'output': [['Novartis', 'ORG', 'Has', 'Kisqali', 'PRODUCT'], ['Kisqali', 'PRODUCT', 'Won', 'Breakthrough Therapy Designation', 'ORG/REG'], ['Kisqali', 'PRODUCT', 'Treat', 'Some Breast Cancer Patients', 'GPE'], ['Kisqali', 'PRODUCT', 'Combination With', 'Tamoxifen', 'PRODUCT'], ['Kisqali', 'PRODUCT', 'Combination With', 'Aromatase Inhibitor', 'PRODUCT'], ['Phase III MONALEESA-7 Trial', 'EVENT', 'Demonstrate', 'Kisqali In Combination With Tamoxifen Or An Aromatase Inhibitor Significantly Prolong Progression-Free Survival Compared To Endocrine Therapy Alone', 'PRODUCT'], ['Michael Shields', 'PERSON', 'Reporting', 'Reuters', 'ORG'], ['Reuters', 'ORG', 'Editing', 'Maria Sheahan', 'PERSON']]}